Other
Comprehensive treatment
Comprehensive treatment is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
unknown2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completed
AI Multitask Model for HCC Treatment
NCT07157085
completednot_applicable
Clinical Study on Electroacupuncture Therapy for Chronic Neck Pain
NCT01674387
unknown
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
NCT04279782
unknownphase_2
Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis
NCT03945487
Clinical Trials (4)
Showing 4 of 4 trials
NCT07157085
AI Multitask Model for HCC Treatment
NCT01674387Not Applicable
Clinical Study on Electroacupuncture Therapy for Chronic Neck Pain
NCT04279782
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
NCT03945487Phase 2
Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4